| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 0 | 47.402 | 51.533 | 76.773 | 83.489 | 93.330 | 72.909 |
| Total Income - EUR | - | - | 0 | 0 | 47.438 | 51.571 | 77.496 | 83.494 | 93.381 | 72.974 |
| Total Expenses - EUR | - | - | 530 | 798 | 27.519 | 24.387 | 35.850 | 40.869 | 47.061 | 52.413 |
| Gross Profit/Loss - EUR | - | - | -530 | -798 | 19.919 | 27.183 | 41.646 | 42.625 | 46.321 | 20.560 |
| Net Profit/Loss - EUR | - | - | -530 | -798 | 19.445 | 26.708 | 40.873 | 41.915 | 45.405 | 18.700 |
| Employees | - | - | 0 | 0 | 0 | 3 | 3 | 3 | 3 | 3 |
Check the financial reports for the company - Lamar Healthcare Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 65 | 0 | 2.231 | 1.575 | 27.145 | 23.337 | 21.801 | 19.745 |
| Current Assets | - | - | 39 | 14 | 17.020 | 25.871 | 14.048 | 20.104 | 25.360 | 7.044 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 10 | 464 | 462 | 542 |
| Receivables | - | - | 0 | 0 | 6.638 | 25.517 | 4.354 | 19.163 | 23.774 | 368 |
| Cash | - | - | 39 | 14 | 10.382 | 354 | 9.684 | 478 | 1.124 | 6.133 |
| Shareholders Funds | - | - | -486 | -1.275 | 18.194 | 26.758 | 40.922 | 41.992 | 45.454 | 23.841 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 591 | 1.289 | 1.057 | 688 | 271 | 1.449 | 1.707 | 2.948 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Lamar Healthcare Srl